nach oben

Erschienen in:

30.05.2020 | COVID-19 | Letter to the Editor Zur Zeit gratis

Global haemostatic tests in rapid diagnosis and management of COVID-19 associated coagulopathy in acute limb ischaemia

verfasst von: Bingwen Eugene Fan, Yew Woon Chia, Christina Lai Lin Sum, Ponnudurai Kuperan, Stephrene Seok Wei Chan, Li Min Ling, Glenn Wei Leong Tan, Serene Si Ning Goh, Lai Har Wong, Shu Ping Lim, Kian Guan Eric Lim, Hwee Tat Tan, Mui Kia Ang, Soon Lee Lau, Kiat Hoe Ong, Jensen Ng

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Excerpt

To the editor, …

Becker RC (2020) COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis. https://doi.org/10.1007/s11239-020-02134-3 CrossRefPubMedPubMedCentral

Perini P, Nabulsi B, Massoni CB, Azzarone M, Freyrie A (2020) Acute limb ischaemia in two young, non-atherosclerotic patients with COVID-19. Lancet. https://doi.org/10.1016/S0140-6736(20)31051-5 CrossRefPubMedPubMedCentral

Lancé MD (2015) A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis. Thromb J 13:1. https://doi.org/10.1186/1477-9560-13-1 CrossRefPubMedPubMedCentral

Harzallah I, Debliquis A, Drénou B (2020) Lupus anticoagulant is frequent in patients with Covid-19. J Thromb Haemost. https://doi.org/10.1111/jth.14867 CrossRefPubMedPubMedCentral

Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W et al (2020) Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. https://doi.org/10.1056/NEJMc2007575 CrossRefPubMedPubMedCentral

Schouwers SM, Delanghe JR, Devreese KM (2010) Lupus anticoagulant (LAC) testing in patients with inflammatory status: does C-reactive protein interfere with LAC test results? Thromb Res 125(1):102–104. https://doi.org/10.1016/j.thromres.2009.09.001 CrossRefPubMed

Connell NT, Battinelli EM, Connors JM (2020) Coagulopathy of COVID-19 and antiphospholipid antibodies. J Thromb Haemost. https://doi.org/10.1111/jth.14893 CrossRefPubMedPubMedCentral

Walsh M, Moore EE, Moore H, Thomas S, Lune SV, Zimmer D et al (2019) Use of viscoelastography in malignancy-associated coagulopathy and thrombosis: a review. Semin Thromb Hemost 45(04):354–372. https://doi.org/10.1055/s-0039-1688497 CrossRefPubMed

Toukh M, Siemens DR, Black A, Robb S, Leveridge M, Graham CH, Othman M (2014) Thromboelastography identifies hypercoagulablilty and predicts thromboembolic complications in patients with prostate cancer. Thromb Res 133(1):88–95CrossRefPubMed

10.

Panigada M, Bottino N, Tagliabue P et al (2020) Hypercoagulability of COVID-19 patients in intensive care unit. A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. https://doi.org/10.1111/jth.14850 CrossRefPubMed

11.

Ruberto MF, Marongiu F, Mandas A, Mameli A, Porru M, Cianchetti E et al (2018) The venous thromboembolic risk and the clot wave analysis: a useful relationship? Clin Chem Lab Med 56:448–453. https://doi.org/10.1515/cclm-2017-0678 CrossRefPubMed

12.

Tan CW, Cheen MHH, Wong WH et al (2019) Elevated activated partial thromboplastin time-based clot waveform analysis markers have strong positive association with acute venous thromboembolism. Biochem Med 29(2):020710

13.

Tan CW, Low JGH, Wong WH, Chua YY, Goh SL, Ng HJ (2020) Critically ill COVID-19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability. Am J Hematol. https://doi.org/10.1002/ajh.25822 CrossRefPubMedPubMedCentral

14.

Wallace NH, Dumont A, Burns A, Christopher TA, Rinder HM, Kriegel MA, Buckley LM, Erkan D, Lee AI (2016) Thromboelastography in the characterization of coagulation status in antiphospholipid syndrome. Blood 128(22):4983. https://doi.org/10.1182/blood.V128.22.4983.4983 CrossRef

15.

Karen AB, Beverley JH (2010) The utility of thromboelastography (TEG) in the management of patients with isolated antiphospholipid antibodies (aPL) or primary antiphospholipid syndrome (PAPS). Blood 116(21):3179. https://doi.org/10.1182/blood.V116.21.3179.3179 CrossRef

Titel: Global haemostatic tests in rapid diagnosis and management of COVID-19 associated coagulopathy in acute limb ischaemia
verfasst von: Bingwen Eugene Fan
Yew Woon Chia
Christina Lai Lin Sum
Ponnudurai Kuperan
Stephrene Seok Wei Chan
Li Min Ling
Glenn Wei Leong Tan
Serene Si Ning Goh
Lai Har Wong
Shu Ping Lim
Kian Guan Eric Lim
Hwee Tat Tan
Mui Kia Ang
Soon Lee Lau
Kiat Hoe Ong
Jensen Ng
Publikationsdatum: 30.05.2020
Verlag: Springer US
Schlagwort: COVID-19
Erschienen in: Journal of Thrombosis and Thrombolysis / Ausgabe 2/2020
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-020-02165-w

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Nierenkarzinom | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Global haemostatic tests in rapid diagnosis and management of COVID-19 associated coagulopathy in acute limb ischaemia

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Update Innere Medizin

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2020

Impact of prophylactic oseltamivir on INR in patients on stable warfarin therapy

Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE

Monitoring the roles of prothrombin activation fragment 1 and 2 (F1 + 2) in patients with atrial fibrillation receiving rivaroxaban and apixaban

Blood type association with bleeding outcomes at delivery in a large multi-center study

Diagnosis of venous and arterial thromboembolic events in COVID-19 virus-infected patients

Correction to: Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies and the lack of guidelines

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Update Innere Medizin